No Data
Earnings Preview: Repligen to Report Financial Results Pre-market on November 12
$Repligen(RGEN.US)$ is scheduled to release its financial results pre-market on November 12 ET. Earnings PreviewAnalysts estimate $Repligen(RGEN.US)$ to post revenue of USD152.96M for 2024Q3, up 8.33%
Repligen Corporation to Present at Upcoming Investor Conferences
Repligen to Report Third Quarter 2024 Financial Results
MasterControl Honors Excellence at Annual Masters Summit
J.P. Morgan Maintains Repligen(RGEN.US) With Buy Rating, Cuts Target Price to $190
Peptide Therapeutics Industry Report 2024, Featuring Profiles of 30+ Leading Players Including PeptiDream, PolyPeptide, Repligen, X-GEN Pharmaceuticals, Zydus Cadila and More
No Data
No Data